Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
33.78
+2.79 (9.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Zai Lab Employees
Zai Lab had 2,175 employees as of December 31, 2023. The number of employees increased by 139 or 6.83% compared to the previous year.
Employees
2,175
Change (1Y)
139
Growth (1Y)
6.83%
Revenue / Employee
$163,562
Profits / Employee
-$124,528
Market Cap
3.68B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ZLAB News
- 25 days ago - Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
- 4 weeks ago - Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Business Wire
- 5 weeks ago - Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia - Business Wire
- 5 weeks ago - Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer - Business Wire
- 6 weeks ago - Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Business Wire
- 6 weeks ago - Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore - Business Wire
- 6 weeks ago - Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire
- 2 months ago - Zai Lab: Rapidly Improving Outlook Bodes Well For The Future - Seeking Alpha